Patrick B. Lappin
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
- Oncology 8
- Lung Cancer Research Studies 2
-
- PI3K/AKT/mTOR signaling in cancer 3
- Cancer therapeutics and mechanisms 2
- Co-authors
- Thomas A. Zanardi (2 shared papers)James G. Christensen (5 shared papers)Brett H. Simmons (5 shared papers)Farbod Shojaei (4 shared papers)Joseph Hyungwoo Lee (3 shared papers)Wendy Halpern (1 shared paper)Marta L. Corcoran (1 shared paper)Kevin P. Baker (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Toxicologic Pathology (2 papers)Clinical Cancer Research (2 papers)Toxicological Sciences (2 papers)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Patrick B. Lappin
30 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 91
- Rheumatology 329
- Oncology 540
- Pulmonary and Respiratory Medicine 621
- Immunology 373
- Cancer Research 210
Countries citing papers authored by Patrick B. Lappin
This map shows the geographic impact of Patrick B. Lappin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick B. Lappin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick B. Lappin more than expected).
Fields of papers citing papers by Patrick B. Lappin
This network shows the impact of papers produced by Patrick B. Lappin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick B. Lappin. The network helps show where Patrick B. Lappin may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick B. Lappin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 420 | |
| 2 | 2015 | 396 | |
| 3 | 2015 | 230 | |
| 4 | 2006 | 122 | |
| 5 | 2011 | 109 | |
| 6 | 2011 | 66 | |
| 7 | 2012 | 61 | |
| 8 | 2012 | 57 | |
| 9 | 2012 | 54 | |
| 10 | 2012 | 48 | |
| 11 | 2012 | 45 | |
| 12 | 2013 | 37 | |
| 13 | 2017 | 34 | |
| 14 | 2015 | 32 | |
| 15 | 2014 | 29 | |
| 16 | 2012 | 22 | |
| 17 | 2014 | 21 | |
| 18 | 2005 | 21 | |
| 19 | 2014 | 20 | |
| 20 | 1997 | 19 |
About Patrick B. Lappin
Patrick B. Lappin is a scholar working on Oncology, Molecular Biology, Biochemistry, Small Animals and Hepatology, having authored 30 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Lung Cancer Research Studies (2 papers), Infectious Diseases and Mycology (2 papers), Cancer therapeutics and mechanisms (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Rheumatology (329 citations), Oncology (540 citations), Pulmonary and Respiratory Medicine (621 citations), Immunology (373 citations) and Cancer Research (210 citations). Patrick B. Lappin has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Thomas A. Zanardi, James G. Christensen, Brett H. Simmons, Farbod Shojaei, Joseph Hyungwoo Lee, Wendy Halpern, Marta L. Corcoran, Kevin P. Baker, Wendy Cai and John Zhong. Their work appears in journals such as Toxicology and Applied Pharmacology, Cancer Chemotherapy and Pharmacology, Toxicologic Pathology, Clinical Cancer Research and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.